香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 证券代码：600332 证券简称：白云山 公告编号：2025－082 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出的。 茲刊載廣州白雲山醫藥集團股份有限公司（「本公司」）在上海證券交易所網站(www.sse.com.cn)刊登的 本公司第九屆董事會第三十一次會議決議公告之中文全文，僅供參考。 廣州白雲山醫藥集團股份有限公司 董事會 中國廣州，2025年12月1日 於本公告日，本公司董事會成員包括執行董事李小軍先生、陳傑輝先生、程寧女士、程洪進先生、 唐和平先生與黎洪先生，及獨立非執行董事陳亞進先生、黃民先生、黃龍德先生與孫寶清女士。 广州白云山医药集团股份有限公司 第九届董事会第三十一次会议决议公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内 容的真实性、准确性和完整性承担法律责任。 广州白云山医药集团股份有限公司（"本 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 擬進行的 出售應收賬款資產的交易 本次交易背景 於2025年12月1日，董事會通過了關於廣州醫藥開展應收賬款資產證券化業務的議案。據此，廣州醫 藥作為賣方及原始權益人擬與計劃管理人簽訂基礎資產買賣協議，向計劃管理人出售基礎資產（定義 見下文），而計劃管理人作為買方同意根據基礎資產買賣協議的條款購買基礎資產並設立專項計劃發 行總額不超過人民幣30億元的資產支持證券，同時亦擔任專項計劃的管理人。計劃管理人將在上交 所批准上述發行之日起計算的2年內分期發行專項計劃，每期專項計劃的存續期不超過2年。截至本 公告日，廣州醫藥尚未就擬進行的本次交易簽署任何具有法律約束力的協議。 擬簽署的基礎資產買賣協議的主要條款 截至本公告日，廣州醫藥與計劃管理人擬簽署的基礎資產買賣協議將包含以下的主要條款： 1. 將予出售的廣州醫藥基礎資產（「基礎資產」） 基礎資產指廣州醫藥及其子公司基於藥品銷售、醫療器械銷售等業務對公立二級及 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 廣州白雲山醫藥集團股份有限公司 （「本公司」） 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 1. 股份分類 普通股 股份類別 H 於香港聯交所上市 (註1) 是 證券代號 (如上市) 00874 說明 香港聯交所上市 H 股 法定/註冊股份數目 面值 法定/註冊股本 上月底結存 219,900,000 RMB 1 RMB 219,900,000 增加 / 減少 (-) RMB 本月底結存 219,900,000 RMB 1 RMB 219,900,000 | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 600332 | 說明 | | 於上海證券交易所 （「上交所」）上市之A股 | | | | | | | | 法 ...

Market Overview - The Hong Kong stock market showed a slight upward trend, with the Hang Seng Index rising by 0.67% to close at 26,033.26 points, and the Hang Seng Tech Index increasing by 0.82% to 5,644.76 points [1] - Major technology stocks mostly rose, with Alibaba up 2.24%, Tencent up 1.31%, and JD Group up 0.52%. However, Xiaomi fell by 1.76% and Meituan dropped by 2.88% [1] - The metals sector saw significant gains, with China Nonferrous Mining rising over 13% [1] - Cryptocurrency-related stocks generally declined, with New Fire Technology Holdings down over 9% [1] Company News - Meituan reported Q3 revenue of 95.5 billion yuan, a year-on-year increase of 2%, but its core local business operating profit turned negative, resulting in a loss of 14.1 billion yuan [2] - China Gas reported revenue of 34.481 billion HKD and a profit of 1.334 billion HKD for the six months ending September 30, 2025 [3] - Yingtong Holdings reported a revenue of 1.028 billion RMB, a year-on-year decrease of 3.42%, but net profit increased by 15.4% to 133 million RMB [3] - Jihai Resources reported a revenue of 450 million RMB, a year-on-year increase of 23.41%, with a net profit of 88.127 million RMB, up 2.98% [3] - Yuhua Education reported annual revenue of 2.497 billion RMB, a year-on-year increase of 5.4%, and a net profit of 930 million RMB, up 133.2% [3] - Huitai Textile reported mid-term revenue of 2.524 billion HKD, a year-on-year decrease of 6.72%, and a net profit of 79.322 million HKD, down 25.77% [3] - Huaxin Handbag International reported revenue of 432 million HKD, a year-on-year increase of 22.55%, and a profit of 48.262 million HKD, up 78.88% [4] Institutional Insights - GF Securities noted that the foundation for a bull market in Hong Kong stocks remains intact, but the evolution may present a "volatile upward, gradually rising" characteristic rather than a rapid increase [12] - Dongwu Securities indicated that short-term risk factors in Hong Kong stocks are decreasing, but a catalyst is needed for confirmation of a rebound [12] - Everbright Securities suggested that compared to previous bull markets, there is still significant room for index growth, but the duration of the bull market may be more important than the magnitude of the increase [12] - CICC highlighted that dividends have become a preferred choice in the current market environment, with the banking sector rebounding nearly 10% since the end of September [13]

FF301 1. 股份分類 普通股 股份類別 H 於香港聯交所上市 (註1) 是 證券代號 (如上市) 00874 說明 香港聯交所上市 H 股 法定/註冊股份數目 面值 法定/註冊股本 上月底結存 219,900,000 RMB 1 RMB 219,900,000 增加 / 減少 (-) RMB 本月底結存 219,900,000 RMB 1 RMB 219,900,000 | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 600332 | 說明 | | 於上海證券交易所 （「上交所」）上市之A股 | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,405,890,949 | RMB | | 1 RMB | | 1,405,890,949 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 ...

Core Insights - Taobao Flash Purchase is making significant moves in the market by launching the "Health Card" and "AI Find Medicine" products, aiming to create a comprehensive health service entry point [1][11] - The platform has accumulated 300 million transaction users since its launch in May, positioning itself as a key player in Alibaba's consumer platform [4][9] - The collaboration with various pharmaceutical brands and technology partners aims to transition from mere drug sales to comprehensive health management services [3][10] Group 1: Product Launch and Features - The "Health Card" will be integrated into the 88VIP membership, offering benefits such as rapid delivery and online consultations with top-tier doctors [1][11] - "AI Find Medicine" is developed in collaboration with Tongyi Lab, utilizing advanced AI to provide personalized medication recommendations based on user queries [11][14] - The AI system is designed to enhance user experience by addressing common issues in online drug purchasing, such as information fragmentation and lack of professional guidance [14][15] Group 2: Market Position and User Engagement - Taobao Flash Purchase has achieved over 90% coverage for 24-hour service, with a 97% on-time delivery rate and over 50% of orders delivered within 19 minutes [6][9] - The online drug retail market share has stabilized above 20%, with the O2O model gaining traction, increasing its share by over 12 percentage points year-on-year [9][10] - The platform leverages Alibaba's extensive user base, including 1 billion members and 380 million health-conscious consumers, to create a "golden traffic pool" for pharmaceutical companies [9][25] Group 3: Strategic Collaborations and Industry Trends - The "Health Guardian Plan" strategic cooperation agreement was signed with multiple pharmaceutical brands to explore digital collaboration in health management [3][10] - The industry is shifting from "instant fulfillment" to "full lifecycle health management services," indicating a broader trend towards digital transformation in healthcare [10][25] - The collaboration aims to enhance the efficiency of pharmaceutical companies and retail pharmacies by utilizing data-driven insights for inventory and marketing strategies [17][22] Group 4: Future Outlook and Competitive Landscape - The integration of AI and instant retail is expected to redefine the competitive landscape, focusing on professional service capabilities and digital health management [25][26] - Taobao Flash Purchase aims to build a new growth curve in the pharmaceutical health sector by leveraging Alibaba's AI algorithms and logistics infrastructure [26] - The emphasis will be on creating a collaborative ecosystem among platforms, pharmaceutical companies, and pharmacies to enhance service delivery and user experience [25][26]

Core Insights - Taobao Flash Purchase has launched two core products: "Health Card" and "AI Find Medicine," marking a significant step in integrating with Alibaba's ecosystem [1] - The "Health Card" will be included as part of the 88VIP membership benefits, enhancing customer engagement and loyalty [1] - Strategic partnerships have been established with various pharmaceutical brands to explore digital cooperation in transitioning from "drug sales" to "health management" [1] Group 1 - The launch of the "Health Card" and "AI Find Medicine" signifies a breakthrough in Taobao Flash Purchase's integration with Alibaba's ecosystem [1] - The "Health Card" will be part of the 88VIP membership, indicating a focus on enhancing user benefits and engagement [1] - Strategic cooperation agreements have been signed with multiple pharmaceutical companies to implement the "Health Guardian Plan," aiming for growth in the health management sector [1] Group 2 - The collaboration includes notable brands such as Kefu, Helion, China Resources Sanjiu, Guoyao Taiji, and Yunnan Baiyao, among others [1] - The initiative aims to provide a clear growth path for the industry amidst the shift towards health management [1] - The partnership with AI Find Medicine, developed by Tongyi Laboratory, emphasizes the technological integration in health services [1]

Market Overview - The Hong Kong stock market showed a mixed performance with the Hang Seng Index rising by 0.81% to 26,068.05 points, the Hang Seng Tech Index up by 0.99% to 5,654.62 points, and the National Enterprises Index increasing by 0.64% to 9,188.61 points [1] - Major technology stocks performed well, with Alibaba up 3.3%, Tencent up 0.82%, and JD Group up 1.29%, while Xiaomi and Meituan saw declines of 2% and 1.46% respectively [1] - The non-ferrous metals sector experienced significant gains, with Minmetals Resources and China Gold International leading the increases [1] - The People's Bank of China made a significant move to stabilize the currency, leading to declines in cryptocurrency-related stocks [1] Company News - Meituan reported third-quarter revenue of 95.5 billion yuan, a year-on-year increase of 2%, but its core local business operating profit turned negative with a loss of 14.1 billion yuan [2] - China Gas announced revenue of 34.481 billion HKD and a profit of 1.334 billion HKD for the six months ending September 30, 2025 [3] - Yingtong Holdings reported a revenue of 1.028 billion RMB, a decrease of 3.42%, but a net profit increase of 15.4% to 133 million RMB [3] - Jihai Resources achieved a revenue of 450 million RMB, a year-on-year increase of 23.41%, with a net profit of 88.127 million RMB, up 2.98% [3] - Yuhua Education reported an annual revenue of 2.497 billion RMB, a 5.4% increase, and a net profit of 930 million RMB, a significant increase of 133.2% [3] - Huitai Textile reported a revenue of 2.524 billion HKD, a decrease of 6.72%, and a net profit of 79.322 million HKD, down 25.77% [3] - New Higher Education Group reported an annual revenue of 2.599 billion RMB, a 7.78% increase, and a net profit of 829 million RMB, up 9.67% [3] - Huaxin Handbag International reported a revenue of 432 million HKD, a year-on-year increase of 22.55%, and a profit of 48.262 million HKD, up 78.88% [4] - Bay Area Development reported toll revenue for October from various highways, showing a year-on-year decrease [4] Institutional Insights - Huatai Securities indicated that the market is nearing a "bad news fully priced" state, suggesting limited downside potential and pointing to left-side layout opportunities [11] - GF Securities noted that the foundation of the Hong Kong bull market remains intact, with a potential for a "volatile upward" trend rather than a rapid increase, highlighting three key triggers for future performance [12] - Dongwu Securities mentioned that short-term risk factors in the Hong Kong market are decreasing, but a rebound confirmation requires catalysts, with current positions being attractive for long-term allocation [12]

数据显示，截至2025年11月28日，中证中药指数(930641)前十大权重股分别为云南白药(000538)、片仔 癀(600436)、同仁堂(600085)、东阿阿胶(000423)、华润三九(000999)、吉林敖东(000623)、白云山 (600332)、众生药业(002317)、以岭药业(002603)、达仁堂(600329)，前十大权重股合计占比54.79%。 中药ETF(159647)，场外联接(A：016891；C：016892；I：022881)。 中邮证券指出，基药目录调整工作有望继续推进，关注中药品种调增机会；中药材呈降价趋势毛利率有 望回升，看好社会库存出清方向以及创新驱动方向。 中药ETF紧密跟踪中证中药指数，中证中药指数选取涉及中药生产与销售等业务的上市公司证券作为样 本，以反映中药概念类上市公司的整体表现。 截至2025年12月1日 10:54，中证中药指数(930641)上涨0.79%，成分股粤万年青(301111)上涨8.41%，太 龙药业(600222)上涨5.22%，江中药业(600750)上涨3.73%，华神科技(000790)上涨3.31%，陇神戎发 (300534) ...

Market Overview - The Hong Kong stock market opened higher on December 1, with the Hang Seng Index rising by 0.34% to 25,945.87 points, the Hang Seng Tech Index increasing by 0.21% to 5,611.02 points, the National Enterprises Index up by 0.31% to 9,158.34 points, and the Red Chip Index gaining 0.1% to 4,197.73 points [1] Company News - Meituan (03690.HK) reported third-quarter revenue of 95.5 billion yuan, a year-on-year increase of 2%, but its core local business operating profit turned negative with a loss of 14.1 billion yuan [2] - China Gas (00384.HK) announced revenue of 34.481 billion HKD and a profit of 1.334 billion HKD for the six months ending September 30, 2025 [3] - Ying Tong Holdings (06883.HK) reported revenue of 1.028 billion RMB for the six months ending September 30, 2025, a decrease of 3.42%, while net profit increased by 15.4% to 133 million RMB [3] - Ji Hai Resources (02489.HK) achieved revenue of 450 million RMB for the nine months ending September 30, 2025, an increase of 23.41%, with net profit rising by 2.98% to 88.127 million RMB [3] - Yuhua Education (06169.HK) reported annual revenue of 2.497 billion RMB for the year ending August 31, 2025, a year-on-year increase of 5.4%, and net profit of 930 million RMB, up 133.2% [3] - Huitai Textile (01382.HK) reported mid-term revenue of 2.524 billion HKD for the six months ending September 30, 2025, a decrease of 6.72%, with net profit down by 25.77% to 79.322 million HKD [3] - New Higher Education Group (02001.HK) reported annual revenue of 2.599 billion RMB for the year ending August 31, 2025, an increase of 7.78%, with net profit rising by 9.67% to 829 million RMB [3] - Huaxin Handbag International Holdings (02683.HK) reported revenue of 432 million HKD for the six months ending September 30, 2025, an increase of 22.55%, with profit rising by 78.88% to 48.262 million HKD [4] - Bay Area Development (00737.HK) reported toll revenue for October from various highways, with total revenues of approximately 208 million HKD, 79.78 million HKD, and 55.312 million HKD, representing year-on-year decreases of 0.5%, 6%, and 11% respectively [4] - Glory Holdings (09998.HK) was awarded a construction contract worth approximately 56.5 million SGD [5] - Haina Star Technology (08297.HK) plans to establish a joint venture with Shandong Hanno to develop high-end liquor business [6] - Vietnam Manufacturing Processing Export (00422.HK) plans to transfer land use rights for two plots in Dong Nai Province for 114 million HKD [7] - Baiyunshan (00874.HK) sold additional basic assets to Xingzheng Asset Management for 440 million HKD [8] - Pag Biopharmaceutical-B (02565.HK) filed for H-share full circulation with the China Securities Regulatory Commission [9] - SMIC (00981.HK) terminated the sale of its stake in SMIC Ningbo [10] Institutional Insights - Everbright Securities noted that compared to previous bull markets, the current index still has significant upside potential, but the duration of the bull market may be more important than the magnitude of the increase under the government's "slow bull" policy guidance. The market may lack strong catalysts in the short term, leading to a period of consolidation [11] - CICC observed that the Hong Kong stock market has been fluctuating and lacking direction over the past two months. In this context, dividend stocks have become a preferred choice. The banking sector has rebounded nearly 10% since the end of September. CICC highlighted three structural trends: AI industry trends, traditional domestic demand, and external demand driving cyclical recovery. The AI industry's advantages lie in ongoing trends and domestic policy support, but it faces challenges with high valuations and expectations [12]